Loading...

Loncar Cancer Immunotherapy ETF

CNCR•NASDAQ
Financial Services
Asset Management
$9.02
$0.14(1.58%)
U.S. Market opens in 4h 34m

Loncar Cancer Immunotherapy ETF (CNCR) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

CNCR Technical Analysis Summary

Loncar Cancer Immunotherapy ETF stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral
Momentum:Bullish to Strongly Bullish (RSI: 0.00)
Trend Strength:Weak (ADX: 0.00)

Technical conditions suggest Loncar Cancer Immunotherapy ETF is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 0.00

Bullish
Oversold, buying opportunity potential.

Takeaway:Insufficient data to determine overall momentum trend.

Trend & Volatility

MACD: 0.00

Neutral
Neutral, momentum shows no clear direction.

ADX: 0.00

Weak
Weak trend, market trading sideways.

ATR (14): 0.00

Low
Low volatility, stable price action.

Takeaway:Insufficient data to determine overall trend and volatility assessment.

Support & Resistance indicators
Bollinger Bands
Upper Band
-
Middle Band (SMA 20)
-
Lower Band
-
Current Position
Unknown
Keltner Channels
Upper Channel
$9.02
Middle Line (EMA 20)
$9.02
Lower Channel
$9.02
Squeeze Status
Unknown

Takeaway:Loncar Cancer Immunotherapy ETF trades near the lower channel, signaling strong support and possible rebound.

Volume & Money Flow Analysis
On-Balance Volume0.00
Money Flow Index50.00Neutral, balanced money flows with no clear signal.
Relative Vigor Index50.00Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:CNCR shows balanced money flow with a slight bullish bias.

Technical Trading Signals Summary
Based on the current technical analysis of Loncar Cancer Immunotherapy ETF, here are the key trading signals and recommendations:

Bullish Signals

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

No significant bearish signals detected.

Overall Recommendation:Insufficient data to provide a recommendation for Loncar Cancer Immunotherapy ETF.

Technical Analysis FAQ